4DMedical Limited Share Price
Stocks
4DX
AU0000095416
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Australian S.E.
09:35:01 17/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 3.740 AUD | +5.65% |
|
+7.04% | -5.22% |
| 16/09 | Lotus Resources Most Shorted Stock on Australian Bourse, ASIC Data Shows | MT |
| 08/09 | ASX Biggest Losers | MT |
| Market Cap | 212.27Cr 151.41Cr 131.21Cr 124.01Cr 112.59Cr 211.01Cr 15TCr 1.48TCr 572.07Cr 7.37TCr 568.76Cr 556.13Cr 23TCr | P/E 2026 |
-151x | P/E 2027 * | -57.1x |
|---|---|---|---|---|---|
| Enterprise Value | 185.83Cr 132.54Cr 114.86Cr 108.56Cr 99Cr 184.72Cr 13TCr 1.3TCr 500.8Cr 6.45TCr 497.9Cr 486.85Cr 21TCr | EV / Sales 2026 |
344x | EV / Sales 2027 * | 82.7x |
| Free-Float |
93.93% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| 4DX | Delayed | |
OTC Markets
| FDMDF | Delayed | |
|
Deutsche Boerse AG
| MQ7 | Delayed | |
|
Tradegate
| MQ7 | Real-time | |
|
Boerse Muenchen
| MQ7 | Real-time |
Last Transcript: 4DMedical Limited
| 1 day | +5.08% | ||
| 1 week | +6.90% | ||
| Current month | +8.77% | ||
| 1 month | +0.27% | ||
| 3 months | +0.27% | ||
| 6 months | -1.85% | ||
| Current year | -5.34% |
| 1 week | 3.31 |  | 3.78 |
| 1 month | 3.31 | | 4.08 |
| Current year | 2.95 | | 7.55 |
| 1 year | 1.4 | | 7.55 |
| 3 years | 0.22 | | 7.55 |
| 5 years | 0.22 | | 7.55 |
| 10 years | 0.22 | | 7.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
CEO | Chief Executive Officer | - | 01/12/2012 |
Julian Sutton
DFI | Director of Finance/CFO | - | 02/01/2026 |
Greg Mogel
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
BRD | Director/Board Member | - | 01/12/2012 |
Lilian Bianchi
CHM | Chairman | - | 02/11/2023 |
John Livingston
BRD | Director/Board Member | - | 01/10/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/06/26 | Buy | Chief Financial Officer | 13,054 | 0.0022% | ||
| 04/03/26 | Exercice | Director | 2,13,464 | 0.0373% | ||
| 04/03/26 | Exercice | Director | 2,13,464 | 0.0373% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.08% | +6.90% | +97.87% | +514.88% | 159.94Cr | |
| +1.10% | +7.06% | +34.88% | +25.78% | 24TCr | |
| -0.48% | +1.71% | +9.39% | -18.37% | 15TCr | |
| +1.36% | +8.22% | -12.02% | +29.35% | 13TCr | |
| +0.09% | -2.34% | -55.64% | -16.99% | 6.36TCr | |
| -1.31% | -0.85% | -19.46% | -16.84% | 4.99TCr | |
| +4.13% | +3.60% | +18.90% | +21.97% | 4.94TCr | |
| +2.28% | +6.18% | +20.83% | +32.59% | 4.24TCr | |
| +0.37% | +3.42% | +38.13% | +51.79% | 4.1TCr | |
| +2.99% | +11.67% | +125.59% | +56.64% | 3.36TCr | |
| Average | +1.56% | +2.57% | +25.85% | +68.08% | 7.99TCr | |
| Weighted average by Cap. | +0.92% | +4.20% | +14.14% | +15.91% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 83.4L 59.49L 51.55L 48.72L 44.23L 82.9L 57Cr 5.82Cr 2.25Cr 29Cr 2.23Cr 2.18Cr 92Cr | 2.28Cr 1.63Cr 1.41Cr 1.33Cr 1.21Cr 2.27Cr 156.01Cr 16Cr 6.14Cr 79Cr 6.11Cr 5.97Cr 252.22Cr |
| Net income | -18Cr -13Cr -11Cr -10Cr -9.39Cr -18Cr -1.21TCr -123.48Cr -48Cr -614.45Cr -47Cr -46Cr -1.96TCr | -3.85Cr -2.75Cr -2.38Cr -2.25Cr -2.04Cr -3.83Cr -263.44Cr -27Cr -10Cr -133.62Cr -10Cr -10Cr -425.9Cr |
| Net Debt | -26Cr -19Cr -16Cr -15Cr -14Cr -26Cr -1.81TCr -184.44Cr -71Cr -917.81Cr -71Cr -69Cr -2.93TCr | -24Cr -17Cr -15Cr -14Cr -13Cr -23Cr -1.62TCr -164.74Cr -64Cr -819.75Cr -63Cr -62Cr -2.61TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | A$3.740 | +5.65% | 27,98,508 |
| 16/26/16 | A$3.540 | -5.35% | 29,32,965 |
| 15/26/15 | A$3.740 | +8.72% | 53,70,439 |
| 14/26/14 | A$3.440 | +2.38% | 27,29,441 |
| 11/26/11 | A$3.360 | -3.45% | 27,68,381 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4DX Stock
Select your edition
All financial news and data tailored to specific country editions
